Danaher to Acquire Cepheid for $4Bn

News   Sep 07, 2016

 
Danaher to Acquire Cepheid for $4Bn
 

RELATED ARTICLES

Agilent Obtains U.S. FDA Approval for GenetiSure Dx Postnatal Assay

News

Agilent Technologies has obtained 510(k) clearance from the FDA for the GenetiSure Dx Postnatal Assay: its first comparative genomic hybridization (CGH) assay for diagnostic use.

READ MORE

Endomag Receives CE Mark Approval for Magseed Breast Cancer Localisation Technology

News

Endomag can now use Magseed, an accurate marker for surgeons to use during breast cancer removal surgery.

READ MORE

Institute of Pathology Joins Thermo Fisher Scientific to Drive Oncology Companion Diagnostic Development

News

Institute of Pathology Heidelberg collaborates with Thermo Fisher Scientific to establish the Next Generation Sequencing Companion Dx Center of Excellence Program in Europe.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE